CEGIR is a multifaceted, collaborative effort between academic medical centers, NIH scientists, and patient advocacy groups, who help ensure the needs of the patients are recognized and met. CEGIR focuses on research projects involving patients with eosinophilic esophagitis (EoE), eosinophilic gastritis (EG), and/or eosinophilic colitis (EC). Learn more about the clinical studies that CEGIR is conducting.
Trials That Are Currently Enrolling:
OMEGA-A Prospective, Multicenter Study to Compare and Validate Endoscopic, Histologic, Molecular and Patient-Reported Outcomes in Pediatric and Adult Patients with Eosinophilic Esophagitis (EoE), Gastritis (EG), Gastroenteritis (EGE) and Colitis (EC)
Ages: 3-65
Study Reference:NCT02523118
Study Type: Observational
Location: Multiple locations in U.S.
Learn more
Download the flyer